Suppr超能文献

与抗原复合的抗组氨酸标签抗体3D5单链片段的晶体结构。

Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.

作者信息

Kaufmann Markus, Lindner Peter, Honegger Annemarie, Blank Kerstin, Tschopp Markus, Capitani Guido, Plückthun Andreas, Grütter Markus G

机构信息

Biochemisches Institut, Universität Zürich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

出版信息

J Mol Biol. 2002 Apr 19;318(1):135-47. doi: 10.1016/S0022-2836(02)00038-4.

Abstract

The crystal structure of a mutant form of the single-chain fragment (scFv), derived from the monoclonal anti-His tag antibody 3D5, in complex with a hexahistidine peptide has been determined at 2.7 A resolution. The peptide binds to a deep pocket formed at the interface of the variable domains of the light and the heavy chain, mainly through hydrophobic interaction to aromatic residues and hydrogen bonds to acidic residues. The antibody recognizes the C-terminal carboxylate group of the peptide as well as the main chain of the last four residues and the last three imidazole side-chains. The crystals have a solvent content of 77% (v/v) and form 70 A-wide channels that would allow the diffusion of peptides or even small proteins. The anti-His scFv crystals could thus act as a framework for the crystallization of His-tagged target proteins. Designed mutations in framework regions of the scFv lead to high-level expression of soluble protein in the periplasm of Escherichia coli. The recombinant anti-His scFv is a convenient detection tool when fused to alkaline phosphatase. When immobilized on a matrix, the antibody can be used for affinity purification of recombinant proteins carrying a very short tag of just three histidine residues, suitable for crystallization. The experimental structure is now the basis for the design of antibodies with even higher stability and affinity.

摘要

已在2.7埃分辨率下确定了源自单克隆抗组氨酸标签抗体3D5的单链片段(scFv)突变形式与六组氨酸肽复合物的晶体结构。该肽主要通过与芳香族残基的疏水相互作用以及与酸性残基的氢键,结合到轻链和重链可变域界面处形成的一个深口袋中。该抗体识别肽的C末端羧基以及最后四个残基的主链和最后三个咪唑侧链。这些晶体的溶剂含量为77%(v/v),并形成70埃宽的通道,这将允许肽甚至小蛋白质的扩散。因此,抗组氨酸scFv晶体可作为带有组氨酸标签的靶蛋白结晶的框架。scFv框架区域的设计突变导致可溶性蛋白在大肠杆菌周质中高水平表达。重组抗组氨酸scFv与碱性磷酸酶融合时是一种方便的检测工具。当固定在基质上时,该抗体可用于亲和纯化携带仅三个组氨酸残基的非常短标签的重组蛋白,适用于结晶。该实验结构现在是设计具有更高稳定性和亲和力抗体的基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验